NRG Therapeutics Announces International Scientific Advisory Board
Stevenage, UK, 30 March 2023 - NRG Therapeutics, Ltd., an innovative neuroscience company targeting mitochondrial dysfunction, is pleased to announce the formation of its scientific advisory board (SAB), to support and steer its R&D programmes to develop novel small molecule therapies for the treatment of neurodegenerative disorders.
The four founding members of NRG’s International SAB are US-based and bring in-depth translational expertise in neuroscience and drug discovery across chemistry, biology and pharmacology…
In a fiercely competitive recruitment market, how do you make your company irresistible to the best tech talent?
St John's Innovation Centre, in collaboration with Innovate UK EDGE, Taylor Vinters and tech executive search firm Bailey Fisher, are planning an event that will offer invaluable insight into the ways in which founders of tech businesses can recruit and retain talent effectively. The session will share advice on employee engagement, employment structures, corporate culture/purpose, hybrid working/4 day week, DEI, vacancy marketing and hiring practices while also exploring the…
Pharmaron announced today that their Liverpool, UK based Gene Therapy CDMO has received a prestigious grant from the UK Government’s Life Sciences Innovation Manufacturing Fund (LSMIF) to expand their viral vector and DNA manufacturing facilities for more than 8,000 sqM.
This major expansion project will provide a four-fold increase in gene therapy process development and analytical capacity accommodating viral vector, DNA and RNA drug substance, plus drug product formulation. The expansion includes 3,500 sqM for future commercial scale GMP capacity.
The resulting facility will greatly…
Agility Life Sciences, an award-winning formulation development CDMO based in Nottingham, UK, and Solitek, experts in solid state development services for the pharmaceutical, agrochemical and fine chemical industries based in Barcelona, Spain, have entered into a Strategic Partnership agreement in order to accelerate the pharmaceutical development milestones of their clients.
The agreement will see Agility Life Sciences signpost and recommend Solitek’s solid state services to clients, with Solitek reciprocally promoting Agility’s formulation development services. The two organisations have…
As the tide recedes from the recent Spring Budget 2023, we explore what has changed regarding R&D tax incentives and how this may impact the UK’s life sciences and biotech industry.
WHAT IS THE BACKGROUND?
Before going into detail on the research and development (R&D) tax relief changes announced, it is helpful to recap the background.
There are currently two schemes of relief:
1. Designed for small and medium-sized enterprises (SMEs) - consisting of an additional tax deduction combined with a payable credit for loss-makers; and
2. Designed for larger companies and consisting of an R…
Nottingham-based contract research organisation (CRO) Cellomatics Biosciences has been officially presented with the prestigious Queen’s Award for Enterprise for International Trade following significant growth in its export business.
Cellomatics is one of just 232 organisations nationally to be recognised with the prominent award, which this year becomes the King’s Award for Enterprise.
The company was presented with the award by the Lord Lieutenant of Nottingham, Sir John Peace, on Thursday 23 March at a ceremony hosted at Cellomatics’ Head Office in Colwick. The afternoon event was…
AMSBIO is pleased to announce the launch of Extragel, a like-for-like replacement for Matrigel™, GeltrexTM and CultrexTM Basement Membrane Extract (BME).
Available ex-stock, with overnight shipment, Extragel is a reconstituted matrix hydrogel formed by basement membrane components extracted from mouse tumor tissues which are rich in extracellular matrix proteins. Designed to be used undiluted or diluted to a specific protein concentration, Extragel is proven to be a highly effective growth scaffold for in vivo xenograft generation, pluripotent stem cell…
Press release
Macomics and Ono Pharmaceutical Partner to Discover and Develop Macrophage-targeting Antibody Therapy for the Treatment of Cancer
• Worldwide drug discovery collaboration agreement with Ono to develop new antibody drugs against a novel macrophage target of interest in immuno-oncology
• Macomics will develop antibody candidates against a novel target using its ENIGMACTM macrophage drug discovery platform
• Ono has an exclusive option to license global rights to the candidates for further development and commercialization
• Macomics will receive an up-front payment, R&D…
£250m Melbourn Science Park vision including village green for local residents unveiled with full set of artist’s impressions for future site as Bruntwood SciTech submits planning application to help supercharge Cambridgeshire’s life science and tech capacity
- Plans include a co-working hub with shared events space, gastropub and boutique hotel, village green, extensive landscaping and improved transport provision
- £250 million masterplan spanning 390,000 sq ft to include six new builds, three redevelopments and a village green
- New world class office and lab workspace will be offered…
Click here to view the March 2023 edition of The Meeting Place.